Carnegie Mellon University »

Predictive Oncology shares owned by Carnegie Mellon University

Quarter-by-quarter ownership of Predictive Oncology (POAI) shares owned by Carnegie Mellon University from 13F filings

Historical chart of Carnegie Mellon University investment in Predictive Oncology

Tip: Access up to 7 years of quarterly data

All positions including Predictive Oncology held by Carnegie Mellon University consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Predictive Oncology by Carnegie Mellon University

Quarter filed Position value Share count Share price at filing
2024-06-30 $11k 10k 1.04
2024-03-31 $26k 10k 2.55
2023-12-31 $34k 10k 3.29

More positions owned by Carnegie Mellon University

Duolingo Cl A Com (DUOL)
Carmell Therapeutics Corp - US (CTCX)
Innsuites Hospitality Trust Sh Ben Int (IHT)
Predictive Oncology (POAI)

View all positions for Carnegie Mellon University

Top funds holding Predictive Oncology

Vanguard Group
Geode Capital Management
Susquehanna International
State Street Corporation
Csenge Advisory Group
Carnegie Mellon University
Tower Research Capital
Wells Fargo & Company
Advisor Group Holdings
PSI Advisors
National Bank Of Canada /fi/
Bank of America Corporation
Royal Bank of Canada

View all funds holding Predictive Oncology